RETA
Reata Pharmaceuticals Inc
Price:  
172.36 
USD
Volume:  
1,986,840.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

RETA EV/EBITDA

-183.4%
Upside

As of 2025-07-08, the EV/EBITDA ratio of Reata Pharmaceuticals Inc (RETA) is -15.37. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. RETA's latest enterprise value is 5,813.45 mil USD. RETA's TTM EBITDA according to its financial statements is -378.12 mil USD. Dividing these 2 quantities gives us the above RETA EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 8.2x - 12.9x 10.6x
Forward P/E multiples 11.1x - 17.6x 14.8x
Fair Price (125.23) - (145.50) (143.70)
Upside -172.7% - -184.4% -183.4%
172.36 USD
Stock Price
(143.70) USD
Fair Price

RETA EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA